Comparison of the dissolution of metaxalone tablets (Skelaxin) usingUSP apparatus 2 and 3
AUTOR(ES)
Cacace, Janice
FONTE
Springer-Verlag
RESUMO
The purpose of this study was to evaluate the effect of pH on the dissolution behavior of metaxalone in the marketed product Skelaxin tablets. The dissolution was evaluated using United States Pharmacopeia (USP) dissolution Apparatus 2 and 3 at pHs ranging from 1.5 to 7.4 Results from these studies show that the dissolution of this product is pH dependent. At low pH (simulated gastric fluid, pH 1.5), the dissolution of metaxalone from Skelaxin tablets, was less than 10% over 75 minutes; whereas, dissolution at pH 4.5 showed greater than 90% release in the same time period. These results were consistent for both Apparatus 2 and 3. This suggests that Skelaxin Tablets should be considered a delayed release dosage form.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2784857Documentos Relacionados
- Test of dissolution and comparison of in vitro dissolution profiles of coated ranitidine tablets marketed in Bahia, Brazil
- Measurement uncertainty of dissolution test of acetaminophen immediate release tablets using Monte Carlo simulations
- Dissolution test for glibenclamide tablets
- Development of dissolution method for benznidazole tablets
- Applications of USP apparatus 3 in assessing the in vitro release of solid oral dosage forms